Talk:Fasudil

Sygnis Pharma AG has the distribution rights for that class of drugs. Memory Alzheimer's study by ASU and the Translational Genomics Research Institute published in the journal Behavioral Neuroscience. Dr. Matthew Huentelman, a TGen scientist and the paper's first author. Fasudil is used in Japan to aid stroke victims by improving blood flow to the brain.

Information from an article on azcentral.com http://www.azcentral.com/business/articles/2009/02/01/20090201biz-memory0202.html —Preceding unsigned comment added by Qqtpie (talk • contribs) 14:57, 2 February 2009 (UTC)

Inhibitor of Dkk1
New research may answer why many recent Alzheimer's clinical trials have failed mentions its use as an experimental inhibitor of Dkk1 in mice. - Rod57 (talk) 17:29, 29 September 2018 (UTC)

Clinical trials
Would be nice to see a summary of the clinical trials supporting the approval in Japan & China. - And have any been done in in USA/EU/Australia ? - Rod57 (talk) 17:29, 29 September 2018 (UTC)